Silo Pharma Inc.

NASDAQ: SILO · Real-Time Price · USD
0.71
0.02 (2.59%)
At close: Aug 15, 2025, 3:59 PM
0.71
-0.63%
After-hours: Aug 15, 2025, 07:49 PM EDT

Silo Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.91M 3.52M 11.37M 9.84M
Short-Term Investments
3.17M 4.14M 3.12K 420K
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
59.15K 64.98K 70.82K 87.87K
Receivables
n/a n/a 66.01K n/a
Inventory
n/a n/a n/a -61.21K
Other Current Assets
30.96K 15.97K n/a 61.21K
Total Current Assets
7.11M 7.68M 11.57M 10.4M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
241.22K n/a n/a n/a
Total Long-Term Assets
300.36K 64.98K 70.82K 87.87K
Total Assets
7.41M 7.75M 11.64M 10.49M
Account Payables
1.58M 703.49K 364.22K 417.94K
Deferred Revenue
72.1K 72.1K 72.1K 72.1K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
1.66M 775.59K 436.32K 490.04K
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
721.58K 793.68K 865.78K 937.88K
Total Liabilities
2.38M 1.57M 1.3M 1.43M
Total Debt
n/a n/a n/a n/a
Common Stock
449.00 316.00 316.00 9.86K
Retained Earnings
-15.26M -10.87M -7.17M -3.26M
Comprehensive Income
2.42K -6.23K n/a n/a
Shareholders Equity
5.03M 6.18M 10.34M 9.06M
Total Investments
3.17M 4.14M 3.12K 420K